Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)

计划入组 400 人 · 首次发布于 2021 年 3 月 2 日

Thoracoabdominal Asynchrony and Respiratory Distress

计划入组 20 人 · 首次发布于 2020 年 11 月 12 日

Amphetamine Induced Adult Respiratory Distress Syndrome

计划入组 49 人 · 首次发布于 2022 年 11 月 10 日

mesenchymal stem cell therapy (respiratory distress syndrome)

Acute Respiratory Distress Syndrome therapy(ImStem Biotechnology, Inc)

immunological directed cellular therapy (oral, acute respiratory distress syndrome)

Edesa Biotech

Canada

Pneuma Respiratory, Inc.

United States

Japanese Respiratory Society

Japan

Combined mRNA Therapy Shows Promise for Preventing Respiratory Distress in Preterm Infants

BioAegis Therapeutics Initiates Phase 2 Trial of Gelsolin for Acute Respiratory Distress Syndrome

Edesa Biotech's Paridiprubart Shows 25% Mortality Reduction in Phase 3 ARDS Trial